Cytokine-mediated bone resorption in patients with the hyperimmunoglobulin E syndrome.
Hyperimmunoglobulin E syndrome (HIES) is a rare immunodeficiency disorder characterized by increased serum immunoglobulin E levels. Bone fragility is part of this syndrome, which has recently been reported to be also associated with an imbalance in cytokine-secreting lymphocyte subpopulation. It has recently been shown that some cytokines can play a role in the bone fragility following menopause. We therefore investigated six patients (mean age 16.5 +/- 8.5 years) affected by this rare syndrome in order to study their bone remodeling and the possible involvement of cytokines in causing the bone fragility associated with this disease. Three of six patients had suffered long bone fractures; in four of six patients the cortical bone mass measured at the distal radius was two standard deviations below that of the aged-matched controls. Urinary pyridinoline excretion, a marker of bone resorption, was markedly increased in the two youngest patients. Adherent mononuclear cells derived from these patients were cultured in vitro and the bone resorbing activity (BRA) of the culture supernatant was measured by means of a fetal rat long bone assay. The BRA was up to 28% above the basal value. We compared the BRA and the cytokine production by the mononuclear cells of these patients to that of postmenopausal women. The BRA, and the IL1 beta, IL6, and TNF alpha levels in the mononuclear cell culture supernatants were identical for both HIES and postmenopausal women. However, the levels of PGE2 were higher and the levels of interferon-gamma were lower in the HIES patients. In conclusion, increased bone resorption in young patients with the HIES is responsible for the cortical bone loss that leads to a higher incidence of fractures. The high BRA secreted by the mononuclear cells of these patients is similar to that found in mononuclear cells from postmenopausal women. These data provide evidence of potent mononuclear cell activation leading to bone loss in HIES, which could be related to IgE-dependent mechanisms.
Cohen-Solal
M
M
INSERM U349 Centre Viggo Petersen, Hôpital Lariboisière, Paris, France.
Prieur
A M
AM
Prin
L
L
Denne
M A
MA
Launay
J M
JM
Graulet
A M
AM
Brazier
M
M
Griscelli
C
C
de Vernejoul
M C
MC
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000596:Amino Acids / Q000652:urine; D000818:Animals; D001681:Biological Assay; D015519:Bone Density; D001862:Bone Resorption / Q000150:complications / Q000378:metabolism*; D002478:Cells, Cultured; D002648:Child; D002675:Child, Preschool; D017077:Culture Media, Conditioned / Q000737:chemistry; D046508:Culture Techniques / Q000379:methods; D016207:Cytokines / Q000032:analysis*; D015232:Dinoprostone / Q000032:analysis; D005260:Female; D050723:Fractures, Bone; D006801:Humans; D007223:Infant; D007589:Job Syndrome / Q000150:complications / Q000175:diagnosis / Q000378:metabolism*; D007963:Leukocytes, Mononuclear; D008297:Male; D008875:Middle Aged; D017698:Postmenopause / Q000378:metabolism; D051381:Rats; D013057:Spectrum Analysis
D000596:Amino Acids; D017077:Culture Media, Conditioned; D016207:Cytokines; C015484:pyridinoline; D015232:Dinoprostone